In addition, GRP78 is overexpressed on the cell surface of acute myeloid leukemia (AML) and different leukemic cell lines [30] but not on HSPC making it an attractive target for CAR T cell therapy [31]. This evidence concerns the gene HSPA5 and acute myeloid leukemia.